Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Catecholamines Reduce Dose-dependent Oedema Formation and Inflammatory Reaction in an Isolated Rat Lung Model

CHRISTINE DACHO, ANDREAS DACHO, ANTJE GEISSLER, CHARLOTTE HAUSER, KAI NOWAK and GRIETJE BECK
In Vivo January 2013, 27 (1) 49-56;
CHRISTINE DACHO
1Clinic for Anaesthesiology and Intensive Care Medicine, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cdacho{at}yahoo.de
ANDREAS DACHO
2Clinic for Plastic Surgery, St. Joseph Hospital, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTJE GEISSLER
1Clinic for Anaesthesiology and Intensive Care Medicine, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLOTTE HAUSER
1Clinic for Anaesthesiology and Intensive Care Medicine, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAI NOWAK
3Clinic for Surgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GRIETJE BECK
4Clinic for Anaesthesiology, HSK Clinic, Wiesbaden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: Since we detected that donor dopamine pre-treatment ameliorates lung function after hypothermia and ischaemia/reperfusion in an isolated rat lung model we studied, whether other catecholamines have beneficial effects on lungs. Materials and Methods: Rats were treated with noradrenaline, adrenaline or dobutamine in different doses. Thereafter lungs were explanted, flushed with Perfadex® solution and stored at 4°C for different time periods. Oedema production was measured and inflammatory mediators were analysed after reperfusion and ventilation. Results: Low-dose noradrenaline or dobutamine did not reduce tissue oedema after eight hours of hypothermia, whereas higher doses significantly reduced oedema formation. Low-dose catecholamines did not prevent the inflammatory response, whereas higher doses of beta-receptor-stimulating catecholamines significantly blunted inflammatory reaction. Conclusion: This study demonstrates that adrenergic-receptor-stimulating catecholamines have a protective dose-dependent effect on lungs after hypothermia and ischaemia/reperfusion. Although noradrenaline and dobutamine have similar dose-dependent organ-protective effects to dopamine, they have more side-effects.

  • Lung transplantation
  • cold preservation
  • ischaemia/reperfusion
  • inflammation

The period of hypothermic and ischemic storage during lung transplantation usually ranges between four and eight hours depending on donor location but is kept as short as possible. Hypothermic organ storage is associated with a decreased metabolic rate, a reduction of biochemical reactions and 1.5- to 2.0-fold reduced enzyme activity (1). However, a series of events still occur during hypothermia, such as oxidative stress, sodium pump inactivation, iron release and induction of cell death that induce an up-regulation of pro-inflammatory mediators and an activation of recipient leukocytes after reperfusion (2). As leukocytes do, an intact endothelial cell layer and metabolic sequences are necessary to guarantee appropriate lung function after transplantation.

To improve the number of available organs for transplantation, many experimental and clinical studies examine the impact of donor pre-conditioning. Several promising in vivo and in vitro studies have addressed the improvement of transplant outcome in the donor organ by supplementing preservation solutions with vasodilatators e.g. sodium nitroprusside (3), nitroglycerine (4) or prostaglandins (5); radical scavengers (6, 7), Platelet-activating factor (PAF)-antagonsists (8), anti-inflammatory substances (9), Tumor necrosis factor (TNF)-antagonists (10) or calcium-antagonists (11). Furthermore, whether oxygenation, preservation temperature, reperfusion pressure and ventilation of the transplanted organ could optimize the transplant outcome was analyzed (12-14). Early organ dysfunction after lung transplantation is correlated with warm and cold ischemic time, modes of organ preservation procedures and the extent of donor organ injury. These occur within 72 hours after transplantation and are clinically characterized by non-specific alveolar damage, hypoxaemia, increase of pulmonary artery resistance, and dysfunction of cell membranes including pulmonary oedema formation and leukocyte infiltration (15).

It is known that dopamine significantly reduces cold preservation injury and is able to improve kidney transplantation outcome (16). Benck et al. demonstrated that pre-treatment of organ donors with low-dose dopamine improved the clinical outcome of cardiac allograft recipients after transplantation (17). We have proven these described dopamine effects in an isolated rat lung model and found significantly less oedema formation after cold preservation with subsequent reperfusion and a significant lower expression of inflammatory mediators (18, 19). The aim of the present study was to analyse if other catecholamines beside dopamine, frequently used in the Intensive Care Unit (ICU), are able to protect lungs from oedema formation. Moreover, the influence of catecholamine pre-treatmenton the production of inflammatory mediators, such as cytokine-induced neutrophil chemoattractant-1 (CINC-1), a rat homolog of interleukin-8 (IL-8) and the expression of adhesion molecules was investigated.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Overview of experimental groups.

Materials and Methods

Animals. Wistar rats weighing 300-350 g were obtained from Janvier®, Rennes, France. Animals were kept under standard conditions and were fed standard rodent chow and water. All procedures were performed according to the Guide for the Care and Use of Laboratory Animals published by the National Academy of Sciences (20) and were approved by German federal regulations (RP Karlsruhe, file no.: 35-9185.81/G-122/07).

Anaesthesia and experimental protocol. Animals were anaesthesised by intraperitoneal injection of thiopental (60 mg/kg). An arterial catheter was inserted in the femoral artery to measure the arterial pressure during pre-conditioning time online. A venous catheter was placed in the internal jugular vein to pre-treat the rat for one hour with different catecholamines, dopamine, dobutamine, adrenaline and noradrenaline. During this period the rats were breathing spontaneously.

Catecholamine-pre-conditioning: Rats (n=7) received dobutamine at 2 μg/kg/min (DB2) and dobutamine at 5 μg/kg/min (DB5), noradrenaline at 0.5 μg/kg/min (NA0.5), noradrenaline at 2 μg/kg/min (NA2) and noradrenaline at 5 μg/kg/min (NA5) and adrenaline at 2 μg/kg/min (ADR 2) and adrenaline at 5 μg/kg/min (ADR5), intraveniously for one hour. NaCl and dopamine at 5 μg/kg/min (DA) pre-treated rats served as control groups (n=9). Mean arterial pressure (MAP) was recorded every ten minutes during pre-conditioning (Table I).

During pre-treatment with NA5 (n=8) and ADR5 (μg/kg/min) (n=3), some of the rats died because of hypertonic crises, with subsequent internal bleeding. We consequently cancelled the experiments in these groups. Five animals survived the pre-conditioning time in NA5 group. Lungs were explantated and reperfused directly without cold preservation to analyze CINC-1 in perfusate solution and intercellular-cell-adhesion-molecule-1 (ICAM-1) and vascular-cell-adhesion-molecule-1 (VCAM-1) expression by immunhistochemical staining.

Operative technique: In all groups, a 14-gauge vascular catheter was inserted into the trachea by cervical tracheotomy. The animals were ventilated with a small animal respirator, using 95% O2/5% CO2 gas, a tidal volume of 2 ml and a rate of 60 breaths/min with 2-cm H2O of positive end-expiratory pressure. Median sternotomy and thymectomy were performed to expose the heart-lung block. After heparin injection into the right ventricle (1000 U/kg), a cannula was placed into the main pulmonary artery through the right ventricular outflow tract and secured with 3-0 silk sutures. The left atrium and ventricle were severed to vent blood. A warm (37°C) modified Krebs-Henseleit buffer (NaCl: 118 mM, KCl: 4.7 mM, KH2PO4: 1.2 mM, NaHCO3: 24 mM, MgSO4: 1.2 mM, Glucose: 11.0 mM, CaCl2: 1.7 mM and 2% bovine albumine), containing sodium bicarbonate to maintain the pH at 7.3 to 7.4 at 37°C, was used to perfuse the lung. The heart-lung block was mounted in a perfusion chamber and maintained at 37°C. Reperfusion was performed at a constant flow rate of 5 ml/h.

Cold preservation time and reperfusion: Cold preservation was carried out by flushing the lungs with 20 ml of cold (4°C) Perfadex® solution (Vitrolife AB, Gothenburg, Germany) through the main pulmonary artery. Thereafter, the heart-lung block was stored at 4°C for six and eight hours and was subsequently reperfused at 37°C with warm Krebs-Henseleit solution for different time periods. Lungs not subjected to hypothermic preservation were directly ventilated and perfused for similar time periods. All groups consisted of at least seven animals. Mean pulmonary arterial pressure (PAP) and pulmonary inspiratory pressure (PIP) were measured continuously and recorded every ten minutes (MCG, Hottinger-Baldwin-Messtechnik, Germany). Lung weight was recorded online to assess oedema formation. Remaining lung tissue was frozen in liquid nitrogen and stored at −80°C, or fixed in 4% formaldehyde.

Immunohistology. At the end of all experiments, lungs were snap-frozen in liquid nitrogen. Cryostat sections (3-5 μm) were stained by an indirect immunoperoxidase technique. Briefly, ethanol-fixed sections were first incubated with phosphate buffered saline/bovine albumin (PBS)/(BSA) (5% w/v), and subsequently with 2% H2O2. Thereafter, the sections were incubated for one hour with a primary antibody for ICAM or VCAM (R&D Systems GmbH, Wiesbaden, Germany), followed by extensive washing and were finally incubated with a biotin-conjugated secondary IgG antibody for 1 h. The sections were washed six times in PBS/BSA and incubated with streptavidin-horseradish peroxidase (HRP) for 30 min. Antibody binding was visualised by diaminobenzidine using Vectastain. All sections were counterstained with haematoxylineosin. ICAM-1 and VCAM-1 were assessed semiquantitatively using a graded scale from “+” to “++++” (+: very weakly positive, ++: weakly positive, +++: positive, ++++: strongly positive). More than 20 fields of vision were blindly evaluated under a microscope at a magnification of 40.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Influence of adrenaline, noradrenaline and dobutamine treatment on formation of pulmonary oedema. Rats were pre-treated with adrenaline (ADR), noradrenaline (NA) and dobutamine (DB) 1 h before lung explantation. NaCl and dopamine (DA)-treated rats served as control. The lungs were subjected to cold preservation (cp) for 6 h (A) or 8 h (B), subsequently reperfused with warm Krebs-Henseleit solution and ventilated for 180 min. Lungs not subjected to cold preservation served as additional control. Kaplan Meier analysis was performed using weight increase more than 4 g as an end-point. After 6 h of cold preservation no significant differences were seen. Significant differences between the groups were only observed after 8 h of cold preservation.: NaCl vs. DA #p<0.005 (15), NaCl vs. DB5 *p<0.002, NaCl vs. NA2 §p<0.0001, DA vs. DB2 $p<0.05, DA vs. NA0.5 +p<0.05 (by log-rank-test).

CINC-1. CINC-1 concentration was measured in the perfusion solutions by enzyme-linked immunosorbent assay (ELISA) (R&D Systems GmbH, Wiesbaden, Germany). Sensitivity of the ELISA was <0.08 pg/ml for CINC-1. Each experiment was performed at least five times and the CINC-1 concentration for each individual sample was assessed in triplicate.

Statistical analysis. Data are shown as the mean±SD. Comparisons were made using Wilcoxon's rank sum test and the Mann-Whitney U-test. GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA) was used for statistical analysis. p-Values of p<0.05 were considered significant.

Results

Influence of catecholamine pre-treatment on oedema formation after cold preservation and during reperfusion. To investigate the influence of cold preservation on oedema formation, lungs from ADR2-, NA0.5-, NA2-, NA5-, DB2- and DB5-treated rats were explanted and stored in Perfadex® solution for six and eight hours, subsequently perfused for 180 min with warm Krebs-Henseleit solution and ventilated for three hours. Lungs pre-treated with DA or NaCl were used as positive controls, lungs without cold preservation served as negative controls [ventilated and perfused (vp)]. When cold preservation time was six hours, the increase in lung weight did not significantly differ between lungs that were subjected to cold preservation and lungs that were not (Figure 1A).

After eight hours of cold preservation time (Figure 1B), lung weight increased within 35 min of reperfusion time in the NaCl control group. Oedema formation was clearly shown after 150 min in all DB2-pretreated lungs. This was in contrast to DA treatment, where reperfusion time without oedema formation lasted significantly longer. NA2 and DB5 pre-treatment significantly reduced oedema formation in a DA-like manner. ADR2 and NA0.5 treatment resulted in less oedema than NaCl treatment and showed a tendency towards protection in these lungs.

Influence of cold preservation on inflammatory mediators after pre-treatment with catecholamines. To study if catecholamine pre-conditioning might affect the inflammatory response after reperfusion, we assessed the production of CINC-1 in the perfusate of lungs after 30 and 180 min of reperfusion. NaCl and DA-pre-treated lungs served as controls.

After 30 min, no CINC-1 production was seen at all. In lungs pre-treated with NaCl, DB2, NA0.5 and ADR2, CINC-1 was clearly detectible in the perfusate three hours after reperfusion. As hypothetically argued, this was significantly inhibited by DA, but also NA2, NA5 and DB5 pre-treatment significantly blunted CINC-1 production (Figure 2).

To investigate the expression of adhesion molecules, immunohistochemical staining for ICAM-1 and VCAM-1 was conducted (Table II). As shown in Figure 3, an up-regulation of ICAM-1 was clearly pronounced in NaCl pre-treated lungs (control) without cold preservation. ADR2- and DB2-pre-treated lungs also exhibited a high expression of ICAM-1. Adhesion molecule expression was significantly lower after DA-pre-treatment. Moreover NA0.5, NA2, NA5 and DB5 significantly reduced adhesion molecule expression.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Immunhistological staining of lungs for intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) after pretreatment with adrenaline (ADR), noradrenaline (NA) or dobutamine (DB) for 1 hour without or after cold preservation. NaCl and dopamine (DA) served as control. Rat lungs were directly reperfused without cold preservation (no cp), 6 hours cold preservation (6 h cp) or 8 hours cold preservation (8 h cp) with subsequent reperfusion for 3 hours. Results are expressed semi-quantitatively (+: very weakly-positive, ++: weakly-positive, +++: positive, ++++: strongly-positive).

The production of CINC-1, but also the up regulation of adhesion molecules ICAM-1 and VCAM-1 were significantly reduced by pre-treatment with higher doses of DB and NA. Lower doses of DB and NA, as well as ADR, had no significant effect on inflammation in these lungs.

Discussion

Primarily, the results of the present study confirm that donor stimulation of beta-adrenergic receptors by catecholamines leads to a significant reduction of oedema formation upon reperfusion in lungs after eight hours of cold ischaemia. Moreover, pre-treatment with beta-adrenergic receptor-stimulating catecholamines significantly reduces the production of inflammatory mediators, such as cytokines and adhesion molecules, in rat lungs after reperfusion. These effects were seen in a substance- and dose-dependent manner. But neither noradrenaline nor dobutamine led to better effects than low-dose dopamine.

Influence of catecholamines on pulmonary oedema. The balance between formation and re-absorption of alveolar fluid volume is called alveolar fluid clearance. If alveolar fluid formation overwhelms the clearance capacity, the resulting alveolar oedema causes deterioration of gas exchange across the alveolar epithelium and leads to acute respiratory failure. Ion gradients generated by transported ions drive fluid out of the alveolar spaces (21). At the molecular level, adrenergic (alpha or beta) receptor-mediated effects are based on cAMP-dependent activation or suppression of protein kinase A (PKA) or C (PKC), and on affecting the activation of cAMP response element-binding protein (CREB) and/or nuclear factor-kappa B (NF-κB) (22). Our control lungs presented immediate oedema formation at the beginning of reperfusion after eight hours of hypothermia and reperfusion. Catecholamine pre-treatment minimized this oedema formation in a dose-dependent manner when concentrations preferentially stimulating beta-adrenergic receptors were used (NA and DB in higher doses). As we demonstrated in a previous study, this effect was adrenoreceptor-mediated (19). There is controversy as to which receptor mediates alveolar clearance. It has been reported that NA reduces lung fluid production by the activation of alpha-adrenergic receptors (23, 24) and that beta-adrenergic receptor stimulation increases lung oedema clearance by up-regulation of Na+-channels and Na+/K+-ATPase (25-28). We demonstrated in the present study that even after eight hours of cold preservation the stimulation of beta-receptors by NA and DB leads to significantly reduced oedema formation upon reperfusion in a dose-dependent manner. Lower doses of NA, DB and ADR (more stimulation of alpha-receptors) did not induce a significant effect. In several rat lung studies, Sznaijder et al. demonstrated that increased sodium channel and Na+/K+-ATPase activity stimulate lung fluid clearance and this is mediated by stimulation of beta receptors (29, 30). In contrast Xu et al. postulated that alveolar fluid clearance is mediated via alpha-adrenoceptors in a rat model of acute pancreatitis (31), whereas Azzam reported an increased lung fluid reabsorption via activation of both, alpha1- and beta-receptors, but not alpha2-receptors (32). This was in accordance with our previous study where we found that alpha- and beta-blockade of adrenergic receptors resulted in immediate oedema formation after eight hours of cold preservation and reperfusion (19).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Influence of cold preservation on Cytokine-induced neutrophil chemoattractant-1 (CINC-1) production after pre-treatment with adrenaline, noradrenaline and dobutamine. Rats were treated with adrenaline (ADR), noradrenaline (NA) and dobutamine (DB) as described in Materials and Methods, or left untreated (NaCl), or were pre-treated with dopamine (DA) as control groups. Thereafter the lungs were directly ventilated and perfused with warm Krebs-Henseleit solution for 180 min. CINC-1 concentration was measured in the perfusate solution after 30 min of reperfusion time and at the end of the reperfusion period. Each group consisted of five animals. The results are expressed as mean CINC-1 (pg/ml) ±SD. Significant differences were seen between NaCl vs. DB5 p<0.0001, NaCl vs. NA2 p<0.01, NaCl vs. NA5 p<0.0005, DA vs. DB2 p<0.005, DA vs. NA0.5 p<0.01, DA vs. ADR2 p<0.01.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Influence of adrenaline, noradrenaline and dobutamine treatment on ICAM expression. Rats were treated as described in Materials and Methods. Thereafter the lungs were directly reperfused and ventilated for 180 min. The result of a representative experiment (n=5) is depicted (+: very weakly-positive, ++: weakly-positive, +++: positive, ++++: strongly positive). Magnification × 40.

Influence of catecholamines on inflammation. Several clinical and experimental studies documented a rapid release of proinflammatory cytokines in kidneys (33), liver (34), heart (35) and lung (18, 36) after ischaemia and reperfusion. Whereas most cytokine levels decreased after reperfusion, the chemokine IL-8 significantly increased after reperfusion and correlated negatively with graft function (37). Fisher (38) and de Perrrot (37) demonstrated that high levels of IL-8 in donor lung tissue or bronchoalveolar lavage are associated with an increased risk of death from primary graft dysfunction after transplantation. Another group reported that after two hours of ischaemia, lung injury could be prevented by monoclonal antibody treatment against IL-8 (38, 40). Whereas binding to the alpha-receptor is associated with predominantly immunostimulatory effects (e.g. induction of TNF alpha and IL-1 beta), stimulation of the beta-receptors has usually immunosuppressive consequences (e.g. inhibition of TNF alpha and IL-1 beta, induction of IL-10). Stimulation of both, alpha- and beta-receptors results in predominance of beta-receptor stimulation (41). This is in concordance with our findings that stimulation of alpha-adrenergic receptors by low doses of NA and DB caused an increase in CINC-1 production during reperfusion. However, stimulation of beta adrenergic receptors by higher doses of NA and DB significantly reduced the expression of CINC-1.

The endothelial barrier function is important to prevent vascular leakage and free migration of inflammatory cells into the interstitium with subsequent oedema formation (42). Adhesion molecules are up-regulated on endothelial cells during ischaemia and reperfusion, such as ICAM-1 and VCAM-1 expression by IL-1 and TNF-α (43, 44). Blockade of adhesion molecules at the time of reperfusion results in reduced lung reperfusion injury (45, 46). Our findings support this as lungs with reduced adhesion molecule expression also exhibited significantly less oedema formation and CINC-1 production. Higher levels of adhesion molecules are accompanied by significant lung oedema formation and production of CINC-1. These effects seem to be adrenergic receptor-mediated as adrenergically stimulated lungs exhibit significantly lower levels of ICAM-1 and VCAM-1. However, adrenoceptor blockade leads to an up regulation of adhesion molecules, as we have demonstrated previously (19).

In conclusion, our study demonstrates that pre-treatment with catecholamine-stimulating beta-adrenoceptors, significantly limits the formation of pulmonary oedema in a dose-dependent manner during reperfusion of lungs subjected to prolonged cold preservation. Moreover, beta-receptor-stimulating substances act as anti-inflammatory agents under these conditions, as they inhibit CINC-1 production and the expression of adhesion molecules. But neither NA nor DB seem to be more effective than DA. Additionally, the tested catecholamines have a higher risk of side effects, such as haemodynamical derangement with corresponding consequences, as we saw in rats that died from internal bleeding after ADR5 or NA5 pretreatment. To utilise the protective immunmodulatory effect of catecholamines in clinical routine, more studies need to be conducted to develop new substances without haemodynamic side-effects to protect the available donor organs much better.

Acknowledgements

This study was supported by the Else Kröner Stiftung.

Footnotes

  • ↵* These Authors contributed equally to this work.

  • Received September 21, 2012.
  • Revision received October 18, 2012.
  • Accepted October 22, 2012.
  • Copyright © 2013 The Author(s). Published by the International Institute of Anticancer Research.

References

  1. ↵
    1. Clavien PA,
    2. Harvey PR,
    3. Strasberg SM
    : Preservation and reperfusion injuries in liver allografts: An overview and synthesis of current studies. Transplantation 53: 957-978, 1992.
    OpenUrlCrossRefPubMed
  2. ↵
    1. de Perrot M,
    2. Liu M,
    3. Waddell TK,
    4. Keshavjee S
    : Ischaemia-reperfusion-induced lung injury. Am J Resp Crit Care Med 167: 490-511, 2003.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Yamashita M,
    2. Schmid RA,
    3. Ando K,
    4. Cooper JD,
    5. Patterson GA
    : Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 62: 791-796, 1996.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Fischer S,
    2. Struber M,
    3. Haverich A
    . Current status of lung transplantation: patients, indications, techniques and outcome. Med Klin 97(3): 137-143, 2002.
    OpenUrl
  5. ↵
    1. Thabut G,
    2. Brugiere O,
    3. Leseche G,
    4. Stern JB,
    5. Fradj K,
    6. Hervé P,
    7. Jebrak G,
    8. Marty J,
    9. Fournier M,
    10. Mal H
    : Preventive effect of inhaled nitric oxide and pentoxifylline on ischaemia/reperfusion injury after lung transplantation. Transplantation 71: 1296-1300, 2001.
    OpenUrl
  6. ↵
    1. Inci I,
    2. Erne B,
    3. Arni S,
    4. Jungraithmayr W,
    5. Inci D,
    6. Hillinger S,
    7. Vogt P,
    8. Leskosek B,
    9. Weder W
    : Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischaemia. J Heart Lung Transplant 29(11): 1293-301, 2010.
    OpenUrlPubMed
  7. ↵
    1. Dermirbas A,
    2. Bozoklu S,
    3. Ozdemir A,
    4. Bilgin N,
    5. Haberal N
    : Effect of apha-tocopherol in the prevention of reperfusion injury caused by free oxygen radicals in the canine kidney autotransplantation model. Transplant Proc 25(3): 2274, 2003.
    OpenUrl
  8. ↵
    1. Iwazaki S,
    2. Takeyoshi I I,
    3. Ohwada S,
    4. Sunose Y,
    5. Aiba M,
    6. Tsutsumi H,
    7. Kawashima Y,
    8. Matsumoto K,
    9. Morishita Y
    : FR128998 (a PAF-receptor antagonist) Counters the Increased Pulmonary Vascular Resistance Associated with Ischaemia-Reperfusion Injury in the Canine Lung. Int J Angiol 10(1): 10-14, 2001.
    OpenUrlPubMed
  9. ↵
    1. Hall TS,
    2. Borkon AM,
    3. Gurtner GC,
    4. Brawn J,
    5. Hutchins GM,
    6. Reitz BA,
    7. Baumgartner WA
    : Improved static lung preservation with corticosteroids and hypothermia. J Heart Transplant 7(5): 348-52, 1988.
    OpenUrlPubMed
  10. ↵
    1. Aiba M,
    2. Takeyoshi I,
    3. Sunose Y,
    4. Iwazaki S,
    5. Tsutsumi H,
    6. Ohwada S,
    7. Tomizawa N,
    8. Oriuchi N,
    9. Matsumoto K,
    10. Morishita Y
    : FR167653 ameliorates pulmonary damage in ischaemia-reperfusion injury in a canine lung transplantation model. J Heart Lung Transplant 19(9): 879-86, 2000.
    OpenUrlPubMed
  11. ↵
    1. Yokomise H,
    2. Ueno T,
    3. Yamazaki F,
    4. Keshavjee S,
    5. Slutsky A,
    6. Patterson G
    : The effect of optimal time of administration of verapamil on lung preservation. Transplantation 49: 1039-1043, 1990.
    OpenUrlPubMed
  12. ↵
    1. Javadpour M,
    2. Kelly CJ,
    3. Chen G,
    4. Bouchier-Hayes DJ
    : Thermotolerance induces heat-shock protein 72 expression and protects against ischaemia-reperfusion-induced lung injury. Br J Surg 85: 943-946, 1998.
    OpenUrlCrossRefPubMed
    1. Gasparri RI,
    2. Jannis NC,
    3. Flameng WJ,
    4. Lerut TE,
    5. Van Raemdonck DE
    : Ischemic preconditioning enhances donor lung preservation in the rabbit. Eur J Cardiothorac Surg 16: 639-646, 1999.
    OpenUrlFREE Full Text
  13. ↵
    1. Thabut G,
    2. Brugiere O,
    3. Leseche G,
    4. Stern JB,
    5. Fradj K,
    6. Hervé P,
    7. Jebrak G,
    8. Marty J,
    9. Fournier M,
    10. Mal H
    : Preventive effect of inhaled nitric oxide and pentoxifylline on ischaemia/reperfusion injury after lung transplantation. Transplantation 71: 1296-1300, 2001.
    OpenUrl
  14. ↵
    1. King RC,
    2. Binns OA,
    3. Rodriguez F,
    4. Kanithanon RC,
    5. Daniel TM,
    6. Spotnitz WD,
    7. Tribble CG,
    8. Kron IL
    : Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69: 1681-1685, 2000.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Gottmann U,
    2. Notheisen A,
    3. Brinkkoetter P,
    4. Yard BA,
    5. Waldherr R,
    6. Schnuelle P,
    7. van der Woude FJ,
    8. Braun C
    : Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats. Transplantation 79: 1344-1350, 2005.
    OpenUrlPubMed
  16. ↵
    1. Benck U,
    2. Hoeger S,
    3. Brinkkoetter PT,
    4. Gottmann U,
    5. Doenmez D,
    6. Boesebeck D,
    7. Lauchart W,
    8. Gummert J,
    9. Karck M,
    10. Lehmkuhl HB,
    11. Bittner HB,
    12. Zuckermann A,
    13. Wagner F,
    14. Schulz U,
    15. Koch A,
    16. Bigdeli AK,
    17. Bara C,
    18. Hirt S,
    19. Berchtold-Herz M,
    20. Brose S,
    21. Herold U,
    22. Boehm J,
    23. Welp H,
    24. Strecker T,
    25. Doesch A,
    26. Birck R,
    27. Krämer BK,
    28. Yard BA,
    29. Schnuelle P
    : Effects of donor pretreatment with dopamine on survival after heart transplantation. JACC 58(17): 1766-1777, 2011.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Hanusch C,
    2. Nowak K,
    3. Toerlitz P,
    4. Gill IS,
    5. Song H,
    6. Rafat N,
    7. Brinkkoetter PT,
    8. Leuvenink HG,
    9. Van Ackern KC,
    10. Yard BA,
    11. Beck GC
    : Donor dopamine treatment limits pulmonary oedema and inflammation in lung allografts subjected to prolonged hypothermia. Transplantation 85(10): 1449-1455, 2008.
    OpenUrlPubMed
  18. ↵
    1. Hanusch C,
    2. Hauser C,
    3. Geisler A,
    4. Nowak K,
    5. Dacho A,
    6. Van Ackern K,
    7. Beck G
    : Reduction of oedema formation after preconditioning with dopamine in an isolated rat lung model is mediated by adrenergic receptors. Ann Transplant 16(3): 97-107, 2011.
    OpenUrlPubMed
  19. ↵
    1. National Research Council
    : Guide for the Care and Use of Laboratory Animals. Washington: National Academies Press: Eighth Edition 248p, 2010.
  20. ↵
    1. Matthay MA,
    2. Folkesson HG,
    3. Clerici C
    : Lung epithelial fluid transport and the resolution of pulmonary oedema. Physiol Rev 82: 569-600, 2002.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Minguet S,
    2. Huber M,
    3. Rosenkranz L,
    4. Schamel WW,
    5. Reth M,
    6. Brummer T
    : Adenosine and cAMP are potent inhibitors of the NF-κappa B pathway downstream of immunoreceptors. Eur J Immunol 35: 31-41, 2005.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Doe S,
    2. Woods B,
    3. Perks AM
    : Effects of norepinephrine on lung liquid production by in vitro lungs from fetal guinea pigs. Can J Physiol Pharmacol 76: 967-974, 1998.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Higuchi M,
    2. Murata Y,
    3. Miyake Y,
    4. Hesser J,
    5. Tyner J,
    6. Keegan KA,
    7. Porto M
    : Effects of norepinephrine on lung fluid flow rate in the chronically catheterized fetal lamb. Am J Obstet Gynecol 157: 986-990, 1987.
    OpenUrlPubMed
  24. ↵
    1. Bertorello AM,
    2. Ridge KM,
    3. Chibalin AV,
    4. Katz AI,
    5. Sznajder JI
    : Isoproenterol increases Na+-K+-ATPase activity by membrane insertion of alpha-subunits in lung alveolar cells. Am J Physiol 276: L20-L27, 1999.
    OpenUrlPubMed
    1. Crandall ED,
    2. Heming TA,
    3. Palombo RL,
    4. Goodman BE
    . Effects of terbutaline on sodium transport in isolated perfused rat lung. J Appl Physiol 60: 289-294, 1986.
    OpenUrlAbstract/FREE Full Text
    1. Saldias F,
    2. Lecuona E,
    3. Friedman E,
    4. Barnard ML,
    5. Ridge KM,
    6. Sznajder JI
    : Modulation on lung liquid clearance by isoproenterol in rat lungs. Am J Physiol 274: L694-L701, 1998.
    OpenUrlPubMed
  25. ↵
    1. Saumon G,
    2. Basset G,
    3. Bouchonnet F,
    4. Crone C
    : cAMP and beta-adrenergic stimulation of rat alveolar epithelium. Effects on fluid absorption and paracellular permeability. Pflugers Arch 410: 464-470, 1987.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Salidas F,
    2. Lecuona E,
    3. Comellas AP,
    4. Ridge KM,
    5. Sznajder JI
    : Dopamine restores lung ability to clear oedema in rats exposed to hyperoxia. Am J Respir Crit Care Med 159: 626-633, 1999.
    OpenUrlPubMed
  27. ↵
    1. Barnard M,
    2. Olivera W,
    3. Rutschman O,
    4. Bertorello AM,
    5. Katz AI,
    6. Sznajder JI
    : Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium. Am J Respir Crit Care Med 156: 709-714, 1997.
    OpenUrlPubMed
  28. ↵
    1. Xu J,
    2. Wang Z,
    3. Ma G,
    4. Sagawa M,
    5. Shimazaki M,
    6. Ueda Y,
    7. Sakuma T
    : Endogenous catecholamine stimulates alveolar fluid clearance in rats with acute pancreatitis. Respirology 14: 195-202, 2009.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Azzam ZS,
    2. Adir Y,
    3. Crespo A,
    4. Comellas A,
    5. Lecuona E,
    6. Dada LA,
    7. Krivoy N,
    8. Rutschman DH,
    9. Sznajder JI,
    10. Ridge KM
    : Norepine-phrine increases alveolar fluid reabsorption and Na, K-ATPase activity. Am J Respir Crit Care Med 170(7): 730-736, 2004.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Lemay S,
    2. Rabb H,
    3. Postler G,
    4. Singh AK
    : Predominant and sustained up regulation of gp 130-signaling cytokines and the chemokine MIP-2 in murine renal ischaemia-reperfusion injury. Transplantation 69: 959-963, 2000.
    OpenUrlPubMed
  31. ↵
    1. Gerlach J,
    2. Jörres A,
    3. Nohr R,
    4. Zeilinger K,
    5. Spatkowski G,
    6. Neuhaus P
    : Local liberation of cytokines during liver preservation. Transpl Int 12: 261-265, 1999.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Oz MC,
    2. Liao H,
    3. Naka Y,
    4. Seldomridge A,
    5. Becker DN,
    6. Michler RE,
    7. Smith CR,
    8. Rose EA,
    9. Stern DM,
    10. Pinsky DJ
    : Ischaemia induced interleukin-8 release after human heart transplantation: A potential role for endothelial cells. Circulation 92: II428-II432, 1995.
    OpenUrlPubMed
  33. ↵
    1. Serrick C,
    2. Adoumine R,
    3. Giaid A,
    4. Shennib H
    : The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischaemia reperfusion injury in the lung allograft. Transplantation 58: 1158-1162, 1994.
    OpenUrlPubMed
  34. ↵
    1. de Perrot M,
    2. Sekine Y,
    3. Fischer S,
    4. Waddell TK,
    5. Mcrae K,
    6. Liu M,
    7. Keshavjee S
    : Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165: 211-215, 2002.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Fisher AJ,
    2. Donnelly SC,
    3. Hirani N,
    4. Haslett C,
    5. Strieter RM,
    6. Dark JH,
    7. Corris PA
    : Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 163: 259-265, 2001.
    OpenUrlCrossRefPubMed
    1. Sekido N,
    2. Mukaida N,
    3. Harada A,
    4. Nakanishi I,
    5. Watanabe Y,
    6. Matsushima K
    : Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365(6447): 654-657, 1993.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Bao Z,
    2. Ye Q,
    3. Gong W,
    4. Xiang Y,
    5. Wan H
    : Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int Immunopharmacol 10(2): 259-263, 2010.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Exton JH
    . Mechanism involved in alpha-adrenergic phenomena. Am J Physiol 248: E633-647, 1985.
    OpenUrlPubMed
  38. ↵
    1. Yard BA,
    2. Beck G,
    3. Schnuelle P,
    4. Braun C,
    5. Schaub M,
    6. Bechtler M,
    7. Göttmann U,
    8. Xiao Y,
    9. Breedijk A,
    10. Wandschneider S,
    11. Lösel R,
    12. Sponer G,
    13. Wehling M,
    14. van der Woude FJ
    : Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds. Am J Transplan 4: 22-30, 2004.
    OpenUrl
  39. ↵
    1. Taylor PM,
    2. Rose ML,
    3. Yacoub MH,
    4. Pigott R
    : Induction of vascular adhesion molecule-1 during rejection of human cardiac allografts. Transplantation 54: 451, 1992.
    OpenUrlPubMed
  40. ↵
    1. Stockenhuber F,
    2. Kramer G,
    3. Schenn G
    . Circulating ICAM-1: A novel parameter of graft rejection. Transplant Proc 25: 919, 1993.
    OpenUrlPubMed
  41. ↵
    1. Moore TM,
    2. Khimenko P,
    3. Adkins WK,
    4. Miyasaka M,
    5. Taylor AE
    : Adehesion molecules contribute to ischaemia and reperfusion-induced injury in the isolated rat lung. J Appl Physiol 78: 2245, 1995.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. DeMeester SR,
    2. Molinari MA,
    3. Shiraishi T,
    4. Okabayashi K,
    5. Manchester JK,
    6. Wick MR,
    7. Cooper JD,
    8. Patterson GA
    : Attenuation of rat lung isograft reperfusion injury with a combination of anti-ICAM-1 and anti-beta-2 integrin monoclonal antibodies. Transplantation 62: 1477-1485, 1996.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo
Vol. 27, Issue 1
January-Ferbruary 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Catecholamines Reduce Dose-dependent Oedema Formation and Inflammatory Reaction in an Isolated Rat Lung Model
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Catecholamines Reduce Dose-dependent Oedema Formation and Inflammatory Reaction in an Isolated Rat Lung Model
CHRISTINE DACHO, ANDREAS DACHO, ANTJE GEISSLER, CHARLOTTE HAUSER, KAI NOWAK, GRIETJE BECK
In Vivo Jan 2013, 27 (1) 49-56;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Catecholamines Reduce Dose-dependent Oedema Formation and Inflammatory Reaction in an Isolated Rat Lung Model
CHRISTINE DACHO, ANDREAS DACHO, ANTJE GEISSLER, CHARLOTTE HAUSER, KAI NOWAK, GRIETJE BECK
In Vivo Jan 2013, 27 (1) 49-56;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • H7N9 and Other Pathogenic Avian Influenza Viruses Elicit a Three-Pronged Transcriptomic Signature That Is Reminiscent of 1918 Influenza Virus and Is Associated with Lethal Outcome in Mice
  • Google Scholar

More in this TOC Section

  • Differential Influence of Morinda citrifolia L. Fruit Juice on the Molecular Composition of Human Platelet Rich Fibrin
  • Establishment of a Step-down FSH Superovulation Protocol in Microminipigs for Zygote Collection
  • Modulating ACVRL1 Expression in HMEC1 Cells as a Simplified In Vitro Model for Hereditary Hemorrhagic Telangiectasia (HHT) Type 2 Studies
Show more Experimental Studies

Keywords

  • lung transplantation
  • cold preservation
  • ischaemia/reperfusion
  • Inflammation
In Vivo

© 2026 In Vivo

Powered by HighWire